Congenital factor XIII deficiency in women: A systematic review of literature

Haemophilia

Volumn 19, Issue 6, 2013, Pages

  Sharief, L A T ^a   Kadir, R A ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Factor XIII deficiency; Menorrhagia; Miscarriage; Ovulation bleeding; Postpartum haemorrhage; Pregnancy

Indexed keywords

BLOOD CLOTTING FACTOR 13 CONCENTRATE;

ANTEPARTUM HEMORRHAGE; ARTICLE; BIRTH WEIGHT; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; BREECH PRESENTATION; CESAREAN SECTION; CINAHL; CONSANGUINEOUS MARRIAGE; CRYOPRECIPITATE; DATA BASE; DISSEMINATED INTRAVASCULAR CLOTTING; EMBASE; EMERGENCY SURGERY; EPISTAXIS; ERYTHROCYTE TRANSFUSION; FETUS DEATH; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEMARTHROSIS; HEMOPERITONEUM; HUMAN; HYSTERECTOMY; INFERTILITY; MEDLINE; MENORRHAGIA; MENSTRUATION; NEWBORN DEATH; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; OVARIECTOMY; OVULATION; PERINATAL MORTALITY; POSTPARTUM HEMORRHAGE; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; PUERPERIUM; RECOMMENDED DRUG DOSE; SALPINGOOOPHORECTOMY; SPONTANEOUS ABORTION; SUBSTITUTION THERAPY; SYSTEMATIC REVIEW; TOOTH EXTRACTION; UTERINE ARTERY EMBOLIZATION; VAGINA BLEEDING; VAGINAL DELIVERY;

FACTOR XIII DEFICIENCY; MENORRHAGIA; MISCARRIAGE; OVULATION BLEEDING; POSTPARTUM HAEMORRHAGE; PREGNANCY;

ABORTION, SPONTANEOUS; ABRUPTIO PLACENTAE; DATABASES, FACTUAL; FACTOR XIII DEFICIENCY; FEMALE; HEMORRHAGE; HUMANS; MENORRHAGIA; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY OUTCOME;

EID: 84886639937     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12259     Document Type: Article

References (60)

1. Duckert F, Jung E, Shmerling D. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh 1960; 5: 179.
2. Ivaskevicius V, Seitz R, Kohler HP et al. International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost 2007; 97: 914-21.
3. Muszbek L, Bagoly Z, Cairo A, Peyvandi F. Novel aspects of factor XIII deficiency. Curr Opin Hematol 2011; 18: 366-72.
4. Anwar R. Factor XIII deficiency. Br J Haematol 1999; 107: 468.
5. Karimi M. Factor XIII deficiency. Sem Thromb 2009; 35: 426.
6. Anwar R, Minford A, Gallivan L, Trinh CH, Markham AF. Delayed umbilical bleeding-a presenting feature for factor XIII deficiency: clinical features, genetics, and management. Pediatrics 2002; 109: 32.
7. Duckert F. Documentation of the plasma factor XIII deficiency in man. Ann N Y Acad Sci 1972; 202: 190-9.
8. Asahina T, Kobayashi T, Okada Y, Goto J, Terao T. Maternal blood coagulation factor XIII is associated with the development of cytotrophoblastic shell. Placenta 2000; 21: 388-93.
9. Asahina T, Kobayashi T, Takeuchi K, Kanayama N. Congenital blood coagulation factor XIII deficiency and successful deliveries: a review of the literature. Obstet Gynecol Surv 2007; 62: 255-60.
10. Burrows RF, Ray JG, Burrows EA. Bleeding risk and reproductive capacity among patients with factor XIII deficiency: a case presentation and review of the literature. Obstet Gynecol Surv 2000; 55: 103-8.
11. Boda Z, Pfliegler G, Muszbek L et al. Congenital factor XIII deficiency with multiple benign breast tumours and successful pregnancy with substitutive therapy. A case report. Haemostasis 1989; 19: 348-52.
12. Rodeghiero F, Castaman GC, Di Bona E, Ruggeri M, Dini E. Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Report of a second case. Blut 1987; 55: 45-8.
13. Mikkola H, Muszbek L, Laiho E et al. Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA. Blood 1997; 89: 1279-87.
14. Padmanabhan LD, Mhaskar R, Mhaskar A, Ross CR. Factor XIII deficiency: a rare cause of repeated abortions. Singapore Med J 2004; 45: 186-7.
15. Asahina T, Kobayashi T, Okada Y et al. Studies on the role of adhesive proteins in maintaining pregnancy. Horm Res 1998; 50: 37-45.
16. Kobayashi T, Terao T, Kojima T, Takamatsu J, Kamiya T, Saito H. Congenital factor XIII deficiency with treatment of factor XIII concentrate and normal vaginal delivery. Gynecol Obstet Invest 1990; 29: 235-8.
17. Fisher S, Rikover M, Naor S. Factor 13 deficiency with severe hemorrhagic diathesis. Blood 1966; 28: 34-9.
18. Melo CLS. Riesgo de sangrado y complicaciones ginecoobstetricas en una paciente con deficit de factor XIII. Presentacian de un caso y revision de la literatura. Medunab 2008; 11: 185.
19. Hanke AA, Elsner O, Görlinger K. Spinal anaesthesia and caesarean section in a patient with hypofibrinogenaemia and factor XIII deficiency. Anaesthesia 2010; 65: 641-5.
20. Rott H, Halimeh S, Trobisch H. Successful treatment with a factor XIII-concentrate (Fibrogammin) in pregnancy in a patient with a novel factor-XIII-B-Gene-Mutation. Bangkok, Thailand: Congress World Federation of haemophilia (WFH), 2004. Available at http://www.gzrr.de. Accessed November 13, 2011.
21. Gmez-Garca EB, Poort SR, Stibbe J et al. Two novel and one recurrent missense mutation in the factor XIII A gene in two Dutch patients with factor XIII deficiency. Br J Haematol 2001; 112: 513-8.
22. Saito M, Asakura H, Yoshida T et al. A familial factor XIII subunit B deficiency. Br J Haematol 1990; 74: 290-4.
23. Meili EO. Clinical course and management of severe congenital factor XIII deficiency. Hamostaseologie 2002; 22: 48-52.
24. Hamer JW, Rae BA. A clinical and family study of factor XIII deficiency in a New Zealand family. Aust N Z J Med 1971; 1: 174-7.
25. Singh N, Neeta S, Gupta N et al. Corpus luteal hemorrhage: an unusual manifestation of congenital factor XIII deficiency. Haemophilia 2008; 14: 667-8.
26. Dargaud Y, de Mazancourt P, Rugeri L et al. An unusual clinical presentation of factor XIII deficiency and issues relating to the monitoring of factor XIII replacement therapy. Blood Coagul Fibrinolysis 2008; 19: 447-52.
27. Cerenzia G, Serrao L, Carillo C, Manna MR. Niccoli VS [Congenital factor XIII deficiency in pregnancy. A case report]. Minerva Ginecol 1999; 51: 409-12.
28. Ikkala E, Myllylae G, Nevanlinna HR. Transfusion therapy in factor 13 (F. S. F.) deficiency. Scand J Haematol 1964; 1: 308-12.
29. Takahashi T, Hatao K, Suzukawa M, Oji T. Congenital factor XIII deficiency required high-dose factor XIII concentrate in late pregnancy. Rinsho Ketsueki 2007; 48: 418-20.
30. Girolami A, Cappellato MG, Lazzaro AR, Boscaro M. Type I and type II disease in congenital factor XIII deficiency. A further demonstration of the correctness of the classification. Blut 1986; 53: 411-3.
31. Chakravarty C, Sivakumaran S, Punk J, Singh N, Pandey R, Darlong V. Acute abdomen in a young girl with factor XIII deficiency perianesthetic issues. J Obstet Gynaecol India 2012; 62: 205-6.
32. Girolami A, Burul A, Sticchi A. Congenital deficiency of factor XIII with normal subunit S and lack of subunit A. Report of a new family. Acta Haematol 1977; 58: 17-26.
33. Capellato MG, Lazzaro AR, Marafioti F, Polato G, Girolami A. A new family with congenital factor XIII deficiency showing a deficit of both subunit A and B. Type I factor XIII deficiency. Haematologia (Budap) 1987; 20: 179-87.
34. Koseki S, Souri M, Koga S et al. Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation. Blood 2001; 97: 2667-72.
35. Lovejoy AE, Reynolds TC, Visich JE et al. Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency. Blood 2006; 108: 57-62.
36. Schroeder V, Durrer D, Meili E, Schubiger G, Kohler HP. Congenital factor XIII deficiency in Switzerland: from the worldwide first case in 1960 to its molecular characterisation in 2005. Swiss Med Wkly 2007; 137: 272-8.
37. Lak M, Peyvandi F, Ali Sharifian A, Karimi K, Mannucci PM. Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency. J Thromb Haemost 2003; 1: 1852-3.
38. Bhattacharya M, Biswas A, Ahmed RPH et al. Clinico-hematologic profile of factor XIII-deficient patients. Clin Appl Thromb Hemost 2005; 11: 475-80.
39. Medhaffar M, Elloumi M, Guermazi S et al. Congenital factor XIII deficiency in the south of Tunisia. Pathol Biol 2006; 54: 349-52.
40. Vijapurkar M, Mota L, Shetty S, Ghosh K. Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent. Haemophilia 2009; 15: 199-202.
41. Ivaskevicius V, Windyga J, Baran B et al. Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations. Haemophilia 2007; 13: 649-57.
42. Peyvandi F, Tagliabue L, Menegatti M et al. Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency. Hum Mutat 2004; 23: 98.
43. Naderi M, Eshghi P, Cohan N, Miri-Moghaddam E, Yaghmaee M, Karimi M. Successful delivery in patients with FXIII deficiency receiving prophylaxis: report of 17 cases in Iran. Haemophilia 2012; 18: 773-6.
44. Ivaskevicius V, Biswas A, Loreth R et al. Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency. Haemophilia 2010; 16: 675-82.
45. Ivaskevicius V, Biswas A, Bevans C et al. Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function. Haematologica 2010; 95: 956-62.
46. Ichinose A. Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control. Int J Hematol 2012; 95: 362-70.
47. Inbal A, Kenet G. Pregnancy and surgical procedures in patients with factor XIII deficiency. Biomed Prog 2003; 16: 69-71.
48. Duru NK, Dede M, Acikel CH, Keskin U, Fidan U, Baser I. Outcome of in vitro fertilization and ovarian response after endometrioma stripping at laparoscopy and laparotomy. J Reprod Med 2007; 52: 805-9.
49. Ho H-Y, Lee RK-K, Hwu Y-M, Lin M-H, Su J-T, Tsai Y-C. Poor response of ovaries with endometrioma previously treated with cystectomy to controlled ovarian hyperstimulation. J Assist Reprod Genet 2002; 19: 507-11.
50. Ragni G, Somigliana E, Benedetti F et al. Damage to ovarian reserve associated with laparoscopic excision of endometriomas: a quantitative rather than a qualitative injury. Am J Obstet Gynecol 2005; 193: 1908-14.
51. Koseki-Kuno S, Yamakawa M, Dickneite G, Ichinose A. Factor XIII A subunit-deficient mice developed severe uterine bleeding events and subsequent spontaneous miscarriages. Blood 2003; 102: 4410-2.
52. Ichinose A. Physiopathology and regulation of factor XIII. Thromb Haemost 2001; 86: 57.
53. Peyvandi F, Garagiola I, Menegatti M. Gynecological and obstetrical manifestations of inherited bleeding disorders in women. J Thromb Haemost 2011; 9: 236-45.
54. Carroli G, Cuesta C, Abalos E, Gulmezoglu AM. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol 2008; 22: 999-1012.
55. Peyvandi F, Bidlingmaier C, Garagiola I. Management of pregnancy and delivery in women with inherited bleeding disorders. Semin Fetal Neonatal Med 2011; 16: 311-7.
56. Bolton Maggs PHB, Perry DJ, Chalmers EA et al. The rare coagulation disorders - review with guidelines for management from the United Kingdom Haemophilia Centre Doctors' Organisation. Haemophilia 2004; 10: 593-628.
57. Ananth CV, VanderWeele TJ. Placental abruption and perinatal mortality with preterm delivery as a mediator: disentangling direct and indirect effects. Am J Epidemiol 2011; 174: 99-108.
58. Rooks VJ, Eaton JP, Ruess L, Petermann GW, Keck-Wherley J, Pedersen RC. Prevalence and evolution of intracranial hemorrhage in asymptomatic term infants. AJNR Am J Neuroradiol 2008; 29: 1082-9.
59. Chi C, Kadir RA. Inherited bleeding disorders in pregnancy. Best Pract Res Clin Obstet Gynaecol 2012; 26: 103-17.
60. Kobayashi T, Asahina T, Okada Y, Terao T. Studies on the localization of adhesive proteins associated with the development of extravillous cytotrophoblast. Placenta 1999; 20: 35-53.